Scarica l'app Stockscreener
11.29
0.27%
0.03
Dopo l'orario di chiusura:
11.29
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.26
Aprire:
$11.26
Volume 24 ore:
373.36K
Relative Volume:
1.39
Capitalizzazione di mercato:
$375.64M
Reddito:
$30.43M
Utile/perdita netta:
$-18.15M
Rapporto P/E:
-16.36
EPS:
-0.69
Flusso di cassa netto:
$-9.08M
1 W Prestazione:
-4.00%
1M Prestazione:
-4.24%
6M Prestazione:
-27.35%
1 anno Prestazione:
+113.02%
Intervallo 1D:
$11.02
$11.39
Intervallo di 1 settimana:
$11.02
$12.38
Portata 52W:
$5.24
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Confronta CLPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.29 | 375.64M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
(CLPT) On The My Stocks Page - news.stocktradersdaily.com
ClearPoint Neuro Expands with New Lease Agreement - TipRanks
ClearPoint Neuro May 2025 presentation: Enters ’Fast Forward’ phase after Q1 revenue beat - Investing.com
ClearPoint Neuro (NASDAQ:CLPT) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
Two Sigma Investments LP Makes New $159,000 Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro director sells $132,800 in stock By Investing.com - Investing.com Canada
ClearPoint Neuro director sells $132,800 in stock - Investing.com
ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k By Investing.com - Investing.com India
ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k - Investing.com
ClearPoint Neuro Inc (CLPT) Shares Down 3.01% on Jun 11 - GuruFocus
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Acquired by Bank of America Corp DE - Defense World
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory - Insider Monkey
When (CLPT) Moves Investors should Listen - news.stocktradersdaily.com
ClearPoint Neuro Inc (CLPT) Shares Up 5.25% on Jun 4 - GuruFocus
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint - Yahoo Finance
Ameriprise Financial Inc. Has $635,000 Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (CLPT) Anticipates Boost from AMT-130 Partnersh - GuruFocus
ClearPoint Neuro (CLPT) Anticipates Boost from AMT-130 Partnership | CLPT Stock News - GuruFocus
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - MSN
Northern Trust Corp Reduces Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Millennium Management LLC Acquires 13,866 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro Inc (CLPT) Trading Down 3.83% on May 28 - GuruFocus
Where are the Opportunities in (CLPT) - news.stocktradersdaily.com
ClearPoint Neuro Approves Key Proposals at Annual Meeting - TipRanks
ClearPoint Neuro Inc. (CLPT) Stock Analysis: A Potential 138% Upside in the Medical Device Sector - DirectorsTalk Interviews
ClearPoint Neuro Updates Director Compensation Plan - TipRanks
Oberland Capital’s Investment in ClearPoint Neuro - Global Legal Chronicle
ClearPoint Neuro targets 15–20 new site activations in 2025 while advancing cell and gene therapy initiatives - MSN
Q2 Earnings Estimate for ClearPoint Neuro Issued By B. Riley - Defense World
ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
ClearPoint Neuro’s Earnings Call: Growth Amid Challenges - TipRanks
(CLPT) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q1 2025 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates - MSN
ClearPoint Neuro (CLPT) Confirms Fiscal Year 2025 Revenue Foreca - GuruFocus
ClearPoint Neuro Reports Record Q1 2025 Revenue - TipRanks
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Yahoo Finance
ClearPoint Neuro (CLPT) Reports Strong Q1 Growth and Strategic A - GuruFocus
Clearpoint Neuro earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) Reports Strong Start to FY25 with Record Revenue | CLPT Stock News - GuruFocus
Clearpoint Neuro Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ClearPoint Neuro Reports First Quarter 2025 Results | CLPT Stock News - GuruFocus
Earnings call transcript: ClearPoint Neuro’s Q1 2025 revenue beats forecast - Investing.com Australia
ClearPoint Neuro, Inc. SEC 10-Q Report - TradingView
ClearPoint Neuro Reports Q1 Earnings: Revenue Beat, EPS Miss, Company Affirms FY25 Guidance - Benzinga
CLEARPOINT NEURO Earnings Results: $CLPT Reports Quarterly Earnings - Nasdaq
ClearPoint Neuro Inc (CLPT) Reports Q1 Revenue of $8.5M, Exceedi - GuruFocus
ClearPoint Neuro Reports First Quarter 2025 Results - ACCESS Newswire
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clearpoint Neuro Inc Azioni (CLPT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 09 '25 |
Sale |
13.29 |
21,247 |
282,373 |
243,522 |
0.54%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):